Cambridge Epigenetix
Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
$88M Series B+ ·
Led by Temasek · Source: fundraisingfox.com
Total raised: $93.5M across 2 sourced rounds
All 3 rounds ↓Signals
Cambridge Epigenetix | 728 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $88M | fundraisingfox.com | ||
| Series B+ | undisclosed | cambridge-epigenetix.com | ||
| Series A | $5.5M | genomeweb.com |
Timeline
- Website created
Founders and team
BY
Bobby Yerramilli-Rao FounderSB
Shankar Balasubramian FounderFS
Fiona Stewart Chief Financial OfficerNW
Nathan Williams DevOps EngineerPF
Peter Fromen Chief Executive Officer
Investors
AAhren Innovation Capital
DDNA Capital
GGVlead investor
NNew Science Ventureslead investor
SSequoia
SSyncona Partners LLP
TTemaseklead investor
TThird Point Ventures
- UUniversity of Cambridge
UUniversity of Cambridge Enterprise
Companies like Cambridge Epigenetix
22Strands BiosciencesPre Seed · Mar 2026
PPrecede$83.5M Series B+ · Jan 2026
BBloodless DiagnosticsSeed · Nov 2026
AAniva
GGesynta PharmaSeries B+ · Jul 2025
TTvaster Genkalp$1.25M Series A · Apr 2025
Other companies backed by Temasek
BBedrock Robotics$600M Series B+ · Oct 2026
SSoufflé Therapeutics$135M Series B+ · Oct 2026
TTrueLayer$27M Series B+ · Oct 2026
VVinci$250M Series B+ · Oct 2026
CCyera$400M Series B+ · Sep 2026
TThe Boring Company$3B Series B+ · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cambridge-epigenetix (get a free API key).